World Health Org To Distribute Chinese Vaccines Over U.S. Objections

This would NEVER have happened if Trump was not robbed of the election in 2020.

World Health Org To Distribute Chinese Vaccines Over U.S. Objections

Vaccine distribution network COVAX buys Chinese doses amid questions about efficacy

By: Adam Kredo, WFB, July 12, 2021:

The World Health Organization is set to buy and distribute more than 100 million doses of China’s coronavirus vaccine, against the Biden administration’s wishes.

The White House notified Congress on Monday that COVAX, the WHO’s vaccine distribution network that primarily aids poorer countries, will buy the Chinese-made vaccine, which is widely seen as less effective than the American versions. COVAX has struggled with a shortfall in available vaccines even as the United States shares millions of doses with the world. Chinese pharmaceutical companies Sinovac and Sinopharm are now in line to sell COVAX millions of doses, according to Bloomberg. The Biden administration warned COVAX against relying on the Chinese-made vaccine, and no U.S. funds will be used by the organization to complete the purchase, congressional sources told the Washington Free Beacon.

COVAX’s reliance on the Chinese-produced vaccine comes amid questions about its efficacy. China has obfuscated data on the vaccine’s effectiveness, which some studies say is just 79 percent effective in blocking COVID infections. That is lower than most of the U.S.-made vaccines, which are closer to 95 percent effective. The U.S. government has also published reams of data on vaccines to promote transparency on the issue and encourage Americans to get at least one shot.

Some countries—including the United Arab Emirates, Seychelles, Mongolia, Uruguay, and Chile—that have relied on China’s vaccine have seen a growth in COVID cases. In some cases, doctors who took that vaccine still fell ill. The New York Times reported in June that countries that relied on the Chinese-made vaccine are battling COVID outbreaks, raising further questions about the vaccine’s effectiveness.